Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

Lilly heart drug Effient fails to carve new niche
Reuters
Sun, 08/26/12 - 11:04 am
Tags:
Eli Lilly, Effient, Plavix, Daiichi Sankyo, Sanofi, antiplatelet therapy, Bristol-Myers Squibb
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Forbes
Sun, 08/26/12 - 11:01 am
Tags:
Sanofi, Prasugrel, Plavix, Effient, Daiichi Sankyo, Clopidogrel, antiplatelet therapy, Eli Lilly
China Biotech In Review: Fidelity Starts New VC Fund For China Healthcare
Seeking Alpha
Sun, 04/22/12 - 01:28 pm
Tags:
Fidelity Investments, Daiichi Sankyo, Shanghai Xinshengyuan, Luqa Pharma, Ebernet
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tue, 03/20/12 - 10:35 am
Tags:
Cyclacel, Sapacitabine, cancer, Daiichi Sankyo
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Tags:
Seattle Genetics, Celldex, Arqule, Daiichi Sankyo, JNJ, Medivation, Dendreon, Aveo Pharmaceutical, Ariad Pharmaceuticals, AstraZeneca, Array Biopharma, Oncothyreon
Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture
WSJ Online
Mon, 03/5/12 - 11:03 am
Tags:
GSK, vaccines, Daiichi Sankyo, Japan
ArQule license deal with Daiichi could land $265M
Bizjournals.com
Thu, 11/10/11 - 01:09 pm
Tags:
Arqule, Daiichi Sankyo, kinase inhibitors
Daiichi Sankyo Cuts Full-Year Sales Forecast on Stronger Yen
Bloomberg
Mon, 10/31/11 - 12:00 pm
Tags:
earnings, Daiichi Sankyo
Daiichi Unit Warned By FDA Over Manufacturing
Pharmalot
Wed, 09/14/11 - 11:14 am
Tags:
FDA, warnings, Daiichi Sankyo, Luitpold, drug manufacturing
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Bloomberg
Wed, 08/17/11 - 12:03 pm
Tags:
Zelboraf, Roche, melanoma, FDA, Daiichi Sankyo
Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
Wed, 06/1/11 - 12:35 pm
Tags:
ASCO, melanoma, skin cancer, Yervoy, Bristol-Myers Squibb, Daiichi Sankyo, Roche
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wed, 05/25/11 - 09:28 am
Tags:
Roche, skin cancer, melanoma, vemurafenib, GSK, Bristol-Myers Squibb, Daiichi Sankyo, Yervoy
Ranbaxy Falls Most in 6 Weeks After $1 Billion Fines Report
Bloomberg
Thu, 05/5/11 - 07:31 am
Tags:
Ranbaxy, India, Daiichi Sankyo
Watson confirms Welchol patent challenge
pharmabiz
Sat, 04/23/11 - 11:13 am
Tags:
Watson Pharmaceuticals, Welchol, Daiichi Sankyo, Genzyme
Genomics companies finally bear fruit
Fierce Biotech
Fri, 03/18/11 - 10:24 am
Tags:
genomics, Daiichi Sankyo, Illumina, Life Technologies, Pacific Biosciences
Daiichi Yet to Gain from Ranbaxy Buy
WSJ Online
Tue, 03/15/11 - 09:07 am
Tags:
Daiichi Sankyo, Ranbaxy
Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Bloomberg
Wed, 03/2/11 - 10:33 am
Tags:
Japan, Kyowa Hakko Kirin, Daiichi Sankyo, Plexxikon, Prostrakan, M&A
Daiichi Sankyo nabs tiny Plexxikon in $935M deal
Fierce Biotech
Tue, 03/1/11 - 07:57 am
Tags:
Plexxikon, Daiichi Sankyo, M&A
Daiichi Sankyo Profit Grows 34%
WSJ
Mon, 01/31/11 - 08:13 am
Tags:
Daiichi Sankyo, earnings
Daiichi Sankyo US unit buys Roxro Pharma to gain pain drug SPRIX
The Pharma Letter
Tue, 12/14/10 - 11:03 am
Tags:
Roxro, M&A, Daiichi Sankyo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.